Skip to content

Clinical trials

Terminated Observational Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Observational Status: Terminated Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20082
20091
20102
20111
20121
20142
20162
20172
20182
20193
20212
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University3
Mayo Clinic2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Assistance Publique - Hôpitaux de Paris1
Bayer1
Columbia University1
Dartmouth-Hitchcock Medical Center1
Fate Therapeutics1
Hospital Sirio-Libanes1
Humanity & Health Medical Group Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular27
Liver Neoplasms9
Pancreatic Neoplasms4
Colonic Neoplasms3
Colorectal Neoplasms3
Fibrosis3
Liver Cirrhosis3
Bile Duct Neoplasms2
Biliary Tract Neoplasms2
Carcinoma, Renal Cell2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.